Molecular analysis of chromosome arm 17q gain in neuroblastoma

Genes Chromosomes and Cancer

Volumn 28, Issue 3, 2000, Pages 276-284

  Janoueix Lerosey, Isabelle ^a   Penther, Dominique ^a   Thioux, Martine ^a   De Crémoux, Patricia ^a   Derré, Josette ^a   Ambros, Peter ^b   Vielh, Philippe ^a   Bénard, Jean ^c   Aurias, Alain ^a   Delattre, Olivier ^a  

^a INSTITUT CURIE   (France)

^b CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; NEUROBLASTOMA; ONCOGENE C MYB; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ANEUPLOIDY; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENE AMPLIFICATION; GENES, MYC; HUMANS; INFANT; MALE; MICROSATELLITE REPEATS; NEUROBLASTOMA; NUCLEIC ACID HYBRIDIZATION;

EID: 0034047372     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2264(200007)28:3<276::AID-GCC5>3.0.CO;2-P     Document Type: Article

References (23)

1. Biedler JL, Spengler BA. 1976. A novel abnormality in human neuroblastoma and antifolate-resistant Chinese hamster cell lines in culture. J Natl Cancer Inst 57:683-695.
2. Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F. 1999. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med 340:1954-1961.
3. Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Boecker W, Lampert F, Stoerkel S. 1997. Comparative genomic hybridization (CGH) analysis of neuroblastomas - an important methodological approach in pediatric tumour pathology. J Pathol 181:394-400.
4. Brodeur GM, and Castleberry RP. 1997. Neuroblastoma. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 3rd ed. Philadelphia: Lippincott. pp 761-798.
5. Caligiuri MA, Strout MP, Schichman SA, Mrozek K, Arthur DC, Herzig GP, Baer MR, Schiffer CA, Heinonen K, Knuutila S, Nousiainen T, Ruutu T, Block AW, Schulman P, Pedersen-Bjergaard J, Croce CM, Bloomfield CD. 1996. Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res 56:1418-1425.
6. Caron H, van Sluis P, van Roy N, de Kraker J, Speleman F, Voute PA, Westerveld A, Slater R, Versteeg R. 1994. Recurrent 1;17 translocations in human neuroblastoma reveal non homologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity. Am J Hum Genet 55:341-347.
7. Caron H. 1995. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavorable prognostic markers in neuroblastoma. Med Ped Oncol 24:215-221.
8. de Crémoux P, Thioux M, Peter M, Vielh P, Michon J, Delattre O, Magdelenat H. 1997. Polymerase chain reaction compared with dot blotting for the determination of N-myc gene amplification in neuroblastoma. Int J Cancer 72:518-521.
9. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J. 1996. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380:152-154.
10. Gilbert F, Feder M, Balaban G, Brangman D, Lurie DK, Podolsky R, Rinald V, Vinikoor N, Weisband J. 1984. Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res 44:5444-5449.
11. Kallioniemi A, Kallionemi OP, Sudar D, Rudovitz D, Gray JW, Waldman F, Pinkle D. 1992. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821.
12. Lastowska M, Nacheva E, MacGuckin A, Curtis A, Grace C, Pearson A, Bown N. 1997a. Comparative genomic hybridization study of primary neuroblastoma tumors. Genes Chromosomes Cancer 18:162-169.
13. Lastowska M, Roberts P, Pearson A, Lewis I, Wolstenholme J, Bown N. 1997b. Promiscuous translocations of chromosome arm 17q in human neuroblastomas. Genes Chromosomes Cancer 19: 143-149.
14. Lastowska M, Cotterill S, Pearson A, Roberts P. MacGuckin A, Lewis I, Bown N. 1997c. Gain of chromosome arm 17q predicts unfavorable outcome in neuroblastoma patients. Eur J Cancer 33:1627-1633.
15. Lastowska M, van Roy N, Bown N, Speleman F, Lunec J, Strachan T, Pearson ADJ, Jackson MS. 1998. Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines. Genes Chromosomes Cancer 23:116-122.
16. Meddeb M, Danglot G, Chudoba I, Venuat AM, Benard J, Avet-Loiseau H, Vasseur B, Le Palier D, Terrier-Lacombe MJ, Hartmann O, Bernheim A. 1996. Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high grade neuroblastomas. Genes Chromosomes Cancer 17:156-165.
17. Peter M, Michon J, Vielh P, Neuenschwander S, Nakamura Y, Sonsino E, Zucker JM, Vergnaud G, Thomas G, Delattre O. 1992. PCR assay for chromosome 1p deletion in small neuroblastoma samples. Int J Cancer 52:544-548.
18. Plantaz D, Mohapatra G, Matthay K, Pellarin M, Seeger R, Feuerstein BG. 1997. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol 150:81-89.
19. Schleiermacher G, Peter M, Michon J, Hugot JP, Vielh P, Zucker JM, Magdelenat H, Thomas G, Delattre O. 1994. Two distinct deleted regions on the short arm of chromosome I in neuroblastoma. Genes Chromosomes Cancer 10:275-281.
20. Vandesompele J, van Roy N, van Gele M, Laureys G, Ambros P, Heimann P, Devalck C, Schuuring E, Brock P, Otten J, Gyselinck J, De Paepe A, Speleman F. 1998. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer 23:141-152.
21. Van Roy N, Laureys G, Ching Cheng N, Willem P, Opdenakker, Versteeg R, Speleman F. 1994. 1;17 translocations and other 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer 10:103-114.
22. Van Roy N, Laureys G, van Gele M, Opdenakker G, Miura R, van der Drift P, Chan A, Versteeg R, Speleman F. 1997. Analysis of 1;17 translocation breakpoints in neuroblastomas: implications for mapping of neuroblastoma genes. Eur J Cancer 33:1974-1978.
23. Zhuang Z, Park WS, Pack S, Schmidt L, Vortmeyer AO, Pak E, Pham T, Weil RJ, Candidus S, Lubensky IA, Linehan WM, Zbar B, Weirich G. 1998. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas. Nat Genet 20:66-69.